Suzhou Hengrui Callisy Medical Device

Suzhou Hengrui Callisy Medical Device is a specialized subsidiary of Jiangsu Hengrui Pharmaceuticals focused on the research, development, and commercialization of high-end surgical robotic systems. The company's primary focus is on minimally invasive surgical solutions, specifically its proprietary multi-arm laparoscopic surgical robot. This system is designed to provide surgeons with enhanced precision, stability, and 3D visualization during complex procedures in urology, gynecology, and general surgery. Having received regulatory approval from the NMPA, the company is actively positioning itself as a major domestic competitor in the Chinese surgical robotics market. Suzhou Hengrui Callisy leverages the extensive clinical and commercial infrastructure of its parent company to drive adoption of robotic-assisted surgery. Its operations integrate advanced mechanical engineering with medical software to improve patient outcomes and surgical efficiency.